Changes in Body Composition Predict the Time to Treatment Failure of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma: A Pilot Retrospective Study.
Takafumi YamamotoNorihiro ImaiTeiji KuzuyaShinya YokoyamaKenta YamamotoTakanori ItoYoji IshizuTakashi HondaMasatoshi IshigamiPublished in: Nutrition and cancer (2022)
Supplemental data for this article is available online at https://doi.org/10.1080/01635581.2022.2049322 .